Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Illness characteristics of COVID-19 in children infected with the SARS-CoV-2 Delta variant

View ORCID ProfileErika Molteni, View ORCID ProfileCarole H. Sudre, View ORCID ProfileLiane S. Canas, View ORCID ProfileSunil S. Bhopal, View ORCID ProfileRobert C. Hughes, View ORCID ProfileLiyuan Chen, View ORCID ProfileJie Deng, View ORCID ProfileBenjamin Murray, View ORCID ProfileEric Kerfoot, Michela Antonelli, View ORCID ProfileMark Graham, View ORCID ProfileKerstin Kläser, Anna May, Christina Hu, View ORCID ProfileJoan Capdevila Pujol, View ORCID ProfileJonathan Wolf, View ORCID ProfileAlexander Hammers, View ORCID ProfileTim D. Spector, View ORCID ProfileSebastien Ourselin, View ORCID ProfileMarc Modat, View ORCID ProfileClaire J. Steves, View ORCID ProfileMichael Absoud, View ORCID ProfileEmma L. Duncan
doi: https://doi.org/10.1101/2021.10.06.21264467
Erika Molteni
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erika Molteni
Carole H. Sudre
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
2MRC Unit for Lifelong Health and Ageing, Department of Population Health Sciences, University College London, London, UK
3Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carole H. Sudre
Liane S. Canas
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Liane S. Canas
Sunil S. Bhopal
4Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sunil S. Bhopal
Robert C. Hughes
5Department of Population Health, Faculty of Epidemiology & Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London, UK
MPH MB ChB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert C. Hughes
Liyuan Chen
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Liyuan Chen
Jie Deng
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jie Deng
Benjamin Murray
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Benjamin Murray
Eric Kerfoot
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eric Kerfoot
Michela Antonelli
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Graham
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark Graham
Kerstin Kläser
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kerstin Kläser
Anna May
6ZOE Limited London, UK
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Hu
6ZOE Limited London, UK
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joan Capdevila Pujol
6ZOE Limited London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joan Capdevila Pujol
Jonathan Wolf
6ZOE Limited London, UK
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan Wolf
Alexander Hammers
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
7King’s College London & Guy’s and St Thomas’ PET Centre, London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexander Hammers
Tim D. Spector
8Department of Twin Research and Genetic Epidemiology, King’s College London, London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tim D. Spector
Sebastien Ourselin
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sebastien Ourselin
Marc Modat
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marc Modat
Claire J. Steves
8Department of Twin Research and Genetic Epidemiology, King’s College London, London, UK
9Department of Aging and Health, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Claire J. Steves
Michael Absoud
10Children’s Neurosciences, Evelina London Children’s Hospital, St Thomas’ Hospital, King’s Health Partners, Academic Health Science Centre, London, UK
11Department of Women and Children’s Health, faculty of Life Sciences and Medicine, School of Life Course Sciences, King’s College London, London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael Absoud
Emma L. Duncan
8Department of Twin Research and Genetic Epidemiology, King’s College London, London, UK
12Department of Endocrinology, Guy’s and St Thomas’ NHS Foundation trust, London, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emma L. Duncan
  • For correspondence: emma.duncan@kcl.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The Delta (B.1.617.2) SARS-CoV-2 variant became the predominant UK circulating strain in May 2021. Whether COVID-19 from Delta infection differs to infection with other variants in children is unknown.

Methods Through the prospective COVID Symptom Study, 109,626 UK school-aged children were proxy-reported between December 28, 2020 and July 8, 2021. We selected all symptomatic children who tested positive for SARS-CoV-2 and were proxy-reported at least weekly, within two timeframes: December 28, 2020 to May 6, 2021 (Alpha (B.1.1.7) the main UK circulating variant); and May 26 to July 8, 2021 (Delta the main UK circulating variant). We assessed illness profiles (symptom prevalence, duration, and burden), hospital presentation, and presence of long (≥28 day) illness; and calculated odds ratios for symptoms presenting within the first 28 days of illness.

Findings 694 (276 younger [5-11 years], 418 older [12-17 years]) symptomatic children tested positive for SARS-CoV-2 with Alpha infection and 706 (227 younger and 479 older) children with Delta infection. Median illness duration was short with either variant (overall cohort: 5 days (IQR 2–9.75) with Alpha, 5 days (IQR 2-9) with Delta). The seven most prevalent symptoms were common to both variants. Symptom burden over the first 28 days was slightly greater with Delta compared with Alpha infection (in younger children, 3 (IQR 2–5) with Alpha, 4 (IQR 2–7) with Delta; in older children 5 (IQR 3–8) with Alpha and 6 (IQR 3–9) with Delta infection in older children). The odds of several symptoms were higher with Delta than Alpha infection, including headache and fever. Few children presented to hospital, and long illness duration was uncommon, with either variant.

Interpretation COVID-19 in UK school-aged children due to SARS-CoV-2 Delta strain B.1.617.2 resembles illness due to the Alpha variant B.1.1.7., with short duration and similar symptom burden.

Funding ZOE Limited, UK Government Department of Health and Social Care, Wellcome Trust, UK Engineering and Physical Sciences Research Council, UK Research and Innovation London Medical Imaging & Artificial Intelligence Centre for Value Based Healthcare, UK National Institute for Health Research, UK Medical Research Council, British Heart Foundation and Alzheimer’s Society.

Ethics Ethics approval was granted by KCL Ethics Committee (reference LRS-19/20-18210).

Evidence before this study To identify existing evidence for differences in COVID-19 due to infection with Alpha (B.1.1.7) or Delta (B.1.617.2) SARS-CoV-2 variants, we searched PubMed for peer-reviewed articles and medRxiv for preprint publications between March 1, and September 17, 2021 using keywords (“SARS-CoV-2” OR “COVID-19”) AND (children OR p?ediatric*) AND (“delta variant” OR “B.1.617.2”). We did not restrict our search by language. Of twenty published articles identified in PubMed, we found one case study describing disease presentation associated with Delta variant infection in a child. Another study examining the increase in hospitalization rates of paediatric cases in USA from August 1, 2020 to August 27, 2021 stated that “It is not known whether the B.1.617.2 (Delta) variant […] causes different clinical outcomes in children and adolescents compared with variants that circulated earlier.” Four studies reported cases of transmission of the Delta variant in school and community contexts; and two discussed screening testing in school-aged children (thus not directly relevant to the research question here). Remaining papers did not target paediatric age specifically. We found no studies investigating differences in COVID-19 presentation (e.g., duration, burden, individual symptoms) in school-aged children either in the UK or world-wide.

Added value of this study We describe and compare illness profiles in symptomatic UK school-aged children (aged 5–17 years) with COVID-19 when either Alpha or Delta strains were the predominant circulating SARS-CoV-2 variant. Our data, collected through one of the largest UK citizen science epidemiological initiatives, show that symptom profile and illness duration of COVID-19 are broadly similar between the strains. Although there were slightly more symptoms with Delta than with Alpha, particularly in older children, this was offset by similar symptom duration (whether considered for symptoms individually or for illness overall). Our study adds quantitative information to the debate on whether there are meaningful clinical differences in COVID-19 due to Alpha vs. Delta variants; and contributes to the discussion regarding rationale for vaccinating children (particularly younger children) against SARS-CoV-2.

Implications of all the available evidence Our data confirm that COVID-19 in UK school-aged children is usually of short duration and similar symptom burden, whether due to Delta or Alpha. Our data contribute to epidemiological surveillance from the wider UK population, and we capture common and generally mild paediatric presentations of COVID-19 that might be missed using clinician-based surveillance alone. Our data will also be useful for the vaccination debate.

Competing Interest Statement

Tim D. Spector reports being a consultant for Zoe Limited, during the conduct of the study. Anna May, Christina Hu, Joan Capdevila Pujol, and Jonathan Wolf are employed at ZOE Limited, UK.

Clinical Trial

This is not a clinical trial

Funding Statement

ZOE Limited, UK Government Department of Health and Social Care, Wellcome Trust, UK Engineering and Physical Sciences Research Council, UK Research and Innovation London Medical Imaging & Artificial Intelligence Centre for Value Based Healthcare, UK National Institute for Health Research, UK Medical Research Council, British Heart Foundation and Alzheimers Society.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics approval was granted by KCL Ethics Committee (reference LRS-19/20-18210).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data collected in the ZOE COVID Study App can be shared with other health researchers through the UK National Health Service-funded Health Data Research UK and Secure Anonymised Information Linkage consortium, housed in the UK Secure Research Platform (Swansea, UK). Anonymised data are available to be shared with researchers according to their protocols in the public interest https://web.www.healthdatagateway.org/dataset/594cfe55-96e3-45ff-874c-2c0006eeb881.

https://arxiv.org/abs/2011.00867

  • Abbreviations

    CI
    Confidence Interval
    COVID-19
    coronavirus disease 2019
    FDR
    False discovery rate
    IQR
    inter-quartile range
    KCL
    King’s College London
    LFAT
    Lateral flow antigen test
    ONS
    Office for National Statistics (UK)
    PCR
    polymerase chain reaction
    SARS-CoV-2
    severe acute respiratory syndrome-related coronavirus 2
    UK
    United Kingdom of Great Britain and Northern Ireland
    USA
    United States of America
    WHO
    World Health Organization
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted October 07, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Illness characteristics of COVID-19 in children infected with the SARS-CoV-2 Delta variant
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Illness characteristics of COVID-19 in children infected with the SARS-CoV-2 Delta variant
    Erika Molteni, Carole H. Sudre, Liane S. Canas, Sunil S. Bhopal, Robert C. Hughes, Liyuan Chen, Jie Deng, Benjamin Murray, Eric Kerfoot, Michela Antonelli, Mark Graham, Kerstin Kläser, Anna May, Christina Hu, Joan Capdevila Pujol, Jonathan Wolf, Alexander Hammers, Tim D. Spector, Sebastien Ourselin, Marc Modat, Claire J. Steves, Michael Absoud, Emma L. Duncan
    medRxiv 2021.10.06.21264467; doi: https://doi.org/10.1101/2021.10.06.21264467
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Illness characteristics of COVID-19 in children infected with the SARS-CoV-2 Delta variant
    Erika Molteni, Carole H. Sudre, Liane S. Canas, Sunil S. Bhopal, Robert C. Hughes, Liyuan Chen, Jie Deng, Benjamin Murray, Eric Kerfoot, Michela Antonelli, Mark Graham, Kerstin Kläser, Anna May, Christina Hu, Joan Capdevila Pujol, Jonathan Wolf, Alexander Hammers, Tim D. Spector, Sebastien Ourselin, Marc Modat, Claire J. Steves, Michael Absoud, Emma L. Duncan
    medRxiv 2021.10.06.21264467; doi: https://doi.org/10.1101/2021.10.06.21264467

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Pediatrics
    Subject Areas
    All Articles
    • Addiction Medicine (269)
    • Allergy and Immunology (549)
    • Anesthesia (134)
    • Cardiovascular Medicine (1745)
    • Dentistry and Oral Medicine (238)
    • Dermatology (172)
    • Emergency Medicine (310)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (649)
    • Epidemiology (10770)
    • Forensic Medicine (8)
    • Gastroenterology (582)
    • Genetic and Genomic Medicine (2927)
    • Geriatric Medicine (286)
    • Health Economics (530)
    • Health Informatics (1917)
    • Health Policy (832)
    • Health Systems and Quality Improvement (740)
    • Hematology (289)
    • HIV/AIDS (626)
    • Infectious Diseases (except HIV/AIDS) (12493)
    • Intensive Care and Critical Care Medicine (684)
    • Medical Education (299)
    • Medical Ethics (86)
    • Nephrology (318)
    • Neurology (2778)
    • Nursing (150)
    • Nutrition (431)
    • Obstetrics and Gynecology (553)
    • Occupational and Environmental Health (596)
    • Oncology (1451)
    • Ophthalmology (440)
    • Orthopedics (172)
    • Otolaryngology (254)
    • Pain Medicine (190)
    • Palliative Medicine (56)
    • Pathology (378)
    • Pediatrics (863)
    • Pharmacology and Therapeutics (361)
    • Primary Care Research (333)
    • Psychiatry and Clinical Psychology (2625)
    • Public and Global Health (5331)
    • Radiology and Imaging (1001)
    • Rehabilitation Medicine and Physical Therapy (592)
    • Respiratory Medicine (721)
    • Rheumatology (329)
    • Sexual and Reproductive Health (288)
    • Sports Medicine (278)
    • Surgery (327)
    • Toxicology (47)
    • Transplantation (149)
    • Urology (124)